Steve Schonfeld’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,820
Closed -$94.2K 2576
2025
Q2
$94.2K Buy
+10,820
New +$78.4K ﹤0.01% 1845
2024
Q4
Sell
-55,185
Closed -$507K 2373
2024
Q3
$507K Sell
55,185
-64,376
-54% -$533K ﹤0.01% 1424
2024
Q2
$1.17M Buy
119,561
+31,995
+37% +$390K 0.01% 1128
2024
Q1
$1.32M Buy
+87,566
New +$1.59M 0.01% 1121
2023
Q4
Sell
-149,800
Closed -$2.78M 2200
2023
Q3
$2.78M Buy
149,800
+27,581
+23% +$644K 0.02% 716
2023
Q2
$3.09M Sell
122,219
-62,186
-34% -$1.57M 0.03% 625
2023
Q1
$4.78M Sell
184,405
-512,355
-74% -$13.7M 0.05% 457
2022
Q4
$16.5M Buy
696,760
+454,528
+188% +$12.3M 0.14% 215
2022
Q3
$6.14M Buy
242,232
+88,232
+57% +$3.1M 0.05% 457
2022
Q2
$5.11M Buy
+154,000
New +$6.54M 0.05% 461
2021
Q3
Sell
-9,524
Closed -$1.58M 2459
2021
Q2
$1.58M Buy
9,524
+7,000
+277% +$1.13M 0.02% 792
2021
Q1
$459K Sell
2,524
-5,215
-67% -$1.21M 0.01% 1178
2020
Q4
$1.55M Buy
7,739
+4,230
+121% +$860K 0.02% 674
2020
Q3
$769K Sell
3,509
-9,461
-73% -$2M 0.01% 781
2020
Q2
$2.48M Buy
12,970
+8,641
+200% +$1.51M 0.06% 350
2020
Q1
$671K Buy
+4,329
New +$504K 0.04% 489
2019
Q1
Sell
-112,900
Closed -$5.6M 1266
2018
Q4
$5.6M Buy
+112,900
New +$6.91M 0.22% 126
2018
Q3
Sell
-25,100
Closed -$1.46M 1017
2018
Q2
$1.46M Buy
+25,100
New +$1.23M 0.08% 327

Other funds holding TDOC

Steve Schonfeld's TDOC Position: Q3 2025 in Review

Steve Schonfeld sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 10,820 shares — an estimated $94.2K sold.

Steve Schonfeld first reported a position in TDOC in Q2 2018 and held it in 18 quarters. The position peaked at $16.5M in Q4 2022. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Steve Schonfeld reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Steve Schonfeld sold 10,820 Teladoc Health shares in Q3 2025, an estimated $94.2K.
  • Steve Schonfeld first reported a position in Teladoc Health in Q2 2018 and held it in 18 quarters.
  • Steve Schonfeld's Teladoc Health position peaked at $16.5M in Q4 2022.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.